These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24421886)

  • 61. Antibody Specificity Following a Recent
    Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
    Front Immunol; 2019; 10():1364. PubMed ID: 31275314
    [No Abstract]   [Full Text] [Related]  

  • 62. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
    Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
    Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acquisition of specific antibodies and their influence on cell-mediated immune response in neonatal cord blood after maternal pertussis vaccination during pregnancy.
    Lima L; Molina MDGF; Pereira BS; Nadaf MLA; Nadaf MIV; Takano OA; Carneiro-Sampaio M; Palmeira P
    Vaccine; 2019 May; 37(19):2569-2579. PubMed ID: 30955978
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age.
    Halperin SA; Scheifele D; Barreto L; Pim C; Guasparini R; Medd L; Meekison W; Eastwood BJ
    Pediatr Infect Dis J; 1999 Sep; 18(9):772-9. PubMed ID: 10493336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.
    Gillard J; van Schuppen E; Diavatopoulos DA
    Adv Exp Med Biol; 2019; 1183():53-80. PubMed ID: 31432398
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.
    Wei SC; Tatti K; Cushing K; Rosen J; Brown K; Cassiday P; Clark T; Olans R; Pawloski L; Martin M; Tondella ML; Martin SW
    Clin Infect Dis; 2010 Aug; 51(3):315-21. PubMed ID: 20578875
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diphtheria-tetanus-acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3-CB): a review of its use in the prevention of Bordetella pertussis infection.
    Matheson AJ; Goa KL
    Paediatr Drugs; 2000; 2(2):139-59. PubMed ID: 10937466
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunity to Bordetella pertussis.
    Mills KH
    Microbes Infect; 2001 Jul; 3(8):655-77. PubMed ID: 11445452
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acellular pertussis vaccine composed of genetically inactivated pertussis toxin: safety and immunogenicity in 12- to 24- and 2- to 4-month-old children.
    Podda A; De Luca EC; Titone L; Casadei AM; Cascio A; Peppoloni S; Volpini G; Marsili I; Nencioni L; Rappuoli R
    J Pediatr; 1992 May; 120(5):680-5. PubMed ID: 1578301
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
    Storsaeter J; Hallander HO; Gustafsson L; Olin P
    Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.
    Preston A
    Hum Vaccin Immunother; 2016 May; 12(5):1274-6. PubMed ID: 26889694
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
    Sirivichayakul C; Chanthavanich P; Limkittikul K; Siegrist CA; Wijagkanalan W; Chinwangso P; Petre J; Hong Thai P; Chauhan M; Viviani S
    Hum Vaccin Immunother; 2017 Jan; 13(1):136-143. PubMed ID: 27686283
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H; Kimura M; Ozaki K; Isomura S; Kamiya H; Nii R; Kato T; Horiuchi K; Syukuda Y; Fujita I
    Tokai J Exp Clin Med; 1988; 13 Suppl():15-9. PubMed ID: 2908519
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Highly attenuated Bordetella pertussis strain BPZE1 as a potential live vehicle for delivery of heterologous vaccine candidates.
    Ho SY; Chua SQ; Foo DG; Locht C; Chow VT; Poh CL; Alonso S
    Infect Immun; 2008 Jan; 76(1):111-9. PubMed ID: 17954727
    [TBL] [Abstract][Full Text] [Related]  

  • 77. An overview of the status of acellular pertussis vaccines in practice.
    Lopez AL; Blumberg DA
    Drugs; 1997 Aug; 54(2):189-96. PubMed ID: 9257078
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A trial of acellular pertussis vaccine in hospital workers during the Cincinnati pertussis epidemic of 1993.
    Christie CD; Garrison KM; Kiely L; Gupta RK; Heubi J; Marchant CD
    Clin Infect Dis; 2001 Oct; 33(7):997-1003. PubMed ID: 11528571
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pertussis: challenges today and for the future.
    Cherry JD
    PLoS Pathog; 2013; 9(7):e1003418. PubMed ID: 23935481
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.